BioPlus participated in The Aesthetic Show 2025, North America’s largest aesthetics and plastic surgery exhibition, held in Las Vegas from June 26 to 29. (Source: BioPlus)
Starting on day one, the products attracted strong interest from dermatologists and plastic surgeons across the U.S. “The regeneration effect is fast and post-treatment irritation is minimal,” commented one medical professional after testing the product. The Hair Solution line, designed to improve alleviate scalp concerns such as dryness or irritation and strengthen hair follicles, also drew praise from hair loss clinics for its efficacy and innovation.
This year’s TAS exhibition was particularly meaningful for BioPlus as it marked the official U.S. launch of its HUGRO platform following its certification under the Modernization of Cosmetics Regulation Act (MoCRA), a key validation of product safety and quality required for entry into the American market. The certification reinforced the credibility of the technology and helped accelerate meaningful discussions with local distributors and medical institutions.
A company representative stated, “The overwhelmingly positive response from global professionals, despite it being our first appearance at TAS, clearly reflects how well HUGRO aligns with current market demands and industry trends. We see this exhibition as a strategic springboard to solidify our global presence, particularly in the U.S. aesthetic and medical skincare markets.”
With innovation at its core, BioPlus is poised to expand its global footprint by delivering regenerative solutions that go beyond surface-level beauty and revitalize skin health at the cellular level.